Tammy Lovell

enovacom, France digital health
By Tammy Lovell 07:21 am November 20, 2020
Orange has pledged to invest in the Digital Health 2 (DH2) fund of LBO France — a major player in the private equity sector in France. The investment will be made through its Orange Digital Investment holding and will contribute to the development of innovative eHealth companies in France and Europe. The DH2 fund plans to invest €200 million in eHealth SMEs, such as QuantifiCare, Tribvn...
Popit, Almirall, psoriasis

Credit: Popit

By Tammy Lovell 01:27 am November 12, 2020
Finnish digital health startup Popit and Almirall, a global biopharmaceutical company focused on skin health are collaborating on a support tool for patients with psoriasis. The solution consists of Popit’s consumer smart device that automatically tracks when medication is taken and reminds patients if a dose has been missed via an accompanying app. It uses a unique piece of hardware which the...
Inrupt, NHS, open source, interoperability,
By Tammy Lovell 06:01 am November 11, 2020
Greater Manchester Health and Social Care Partnership in the UK is running a pilot of a web platform which allows users to store their medical data in a Personal Online Data Store - or pod. Startup Inrupt announced the launch of its Enterprise Solid Service (ESS) earlier this week in a blog post, from its chief technology officer, World Wide Web founder Sir Tim Berners-Lee. The secure web...
Sidekick, digital therapeutics

Credit: Sidekick Health

By Tammy Lovell 02:23 am October 28, 2020
Sidekick Health has completed a $20 million (£15.3m) oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII, with participation by existing investors Novator and Frumtak Ventures. The Nordic firm’s fundraising efforts were supported by the EIT Digital Accelerator, a European digital innovation initiative which supports startup and scale-up...

Credit: NVIDIA

By Tammy Lovell 08:17 am October 6, 2020
US tech giant NVIDIA has announced plans to build the UK’s most powerful supercomputer, to help healthcare researchers. The Cambridge-1 supercomputer is expected to come online by the end of the year and is intended for artificial intelligence (AI) research into medical challenges, including those presented by COVID-19. Speaking at his GPU Technology Conference keynote, NVIDIA founder and CEO,...
Butterfly Medical Ltd, Series B, New Rhein Healthcare Investors, Alon Medtech Ventures, medical device

Credit: Butterfly Medical Ltd,

By Tammy Lovell 02:38 am October 6, 2020
Israeli medical device company, Butterfly Medical Ltd, has raised $7 million in a Series B round led by Philadelphia-based New Rhein Healthcare Investors. Butterfly Medical successfully completed the enrolment of 49 patients to its multi-centre clinical study testing its implantable device for patients suffering from benign prostatic hyperplasia (BPH) or an enlarged prostate. Follow-up results...
By Tammy Lovell 01:57 am October 2, 2020
The European Institute of Innovation and Technology (EIT) Health has shared six health tech solutions for healthy ageing to mark the UN International Day of Older Persons today. Healthy ageing is a central part of the EU-backed community of health innovators’ goals to promote better health and a sustainable health economy in Europe. The projects include: FRADE – This technology to detect, screen...
Sophia Genetics, artificial intelligence, funding, Swisscom Ventures

Credit: SOPHiA Genetics  

By Tammy Lovell 08:39 am October 1, 2020
Swiss medical data specialist Sophia Genetics today announced the closing of a $110 million financing round to enter into the next stage of its expansion. The Series F round was led by aMoon, a health tech and life sciences venture fund based in Israel, and Hitachi Ventures, a venture arm of Japanese Hitachi Group. The company also received the trust of prime financial institutions Credit Suisse...

Credit: Abbott

By Tammy Lovell 08:05 am September 21, 2020
Abbott announced that its Libre Sense Glucose Sport Biosensor has achieved a CE Mark, paving the way for a European roll-out.   The Libre Sense biosensor provides continuous glucose monitoring (CGM) to help athletes understand the efficacy of their nutrition choices on training and competition. Based on Abbott's FreeStyle Libre technology for people living with diabetes, it is the first personal-...
By Tammy Lovell 01:04 am September 18, 2020
Swedish firm Joint Academy has raised $23 million in Series B funding for its clinical evidence-based digital treatment for chronic joint pain, which connects patients with licensed physical therapists. The round was led by international investment company Kinnevik and participated in by existing investors Karl-Johan Persson (H&M chairman) and Alfvén & Didrikso. To date, the company,...